Dimensional Fund Advisors’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51M Sell
233,305
-43,054
-16% -$206K ﹤0.01% 2797
2026
Q1
$898K Buy
276,359
+4,081
+1% +$15.7K ﹤0.01% 2861
2025
Q4
$1.08M Sell
272,278
-8,591
-3% -$25.5K ﹤0.01% 2851
2025
Q3
$876K Buy
280,869
+27,980
+11% +$93K ﹤0.01% 2912
2025
Q2
$847K Buy
252,889
+700
+0.3% +$3.32K ﹤0.01% 2917
2025
Q1
$1.07M Sell
252,189
-20,780
-8% -$86.2K ﹤0.01% 2870
2024
Q4
$647K Sell
272,969
-11,036
-4% -$16.3K ﹤0.01% 2995
2024
Q3
$364K Sell
284,005
-20,104
-7% -$27.8K ﹤0.01% 3087
2024
Q2
$465K Sell
304,109
-53,506
-15% -$84.1K ﹤0.01% 3038
2024
Q1
$601K Sell
357,615
-8,319
-2% -$16.6K ﹤0.01% 3011
2023
Q4
$637K Sell
365,934
-13,786
-4% -$25.3K ﹤0.01% 3003
2023
Q3
$718K Sell
379,720
-127,570
-25% -$214K ﹤0.01% 2983
2023
Q2
$746K Sell
507,290
-101,743
-17% -$176K ﹤0.01% 2984
2023
Q1
$1.19M Sell
609,033
-14,838
-2% -$35.3K ﹤0.01% 2866
2022
Q4
$1.4K Buy
623,871
+4
+0% +$9 ﹤0.01% 2821
2022
Q3
$1.5M Sell
623,867
-3,333
-0.5% -$7.84K ﹤0.01% 2793
2022
Q2
$1.3M Sell
627,200
-6,704
-1% -$15.5K ﹤0.01% 2861
2022
Q1
$1.79M Sell
633,904
-18,657
-3% -$62K ﹤0.01% 2860
2021
Q4
$3.05M Sell
652,561
-44,093
-6% -$150K ﹤0.01% 2730
2021
Q3
$1.88M Sell
696,654
-58,846
-8% -$175K ﹤0.01% 2872
2021
Q2
$2.15M Buy
755,500
+17,619
+2% +$51.8K ﹤0.01% 2853
2021
Q1
$2.24M Sell
737,881
-44,010
-6% -$143K ﹤0.01% 2826
2020
Q4
$2.3M Sell
781,891
-17,063
-2% -$51.7K ﹤0.01% 2770
2020
Q3
$2.56M Sell
798,954
-31,733
-4% -$104K ﹤0.01% 2673
2020
Q2
$2.77M Sell
830,687
-21,935
-3% -$79.8K ﹤0.01% 2651
2020
Q1
$3.1M Sell
852,622
-7,697
-0.9% -$34.5K ﹤0.01% 2574
2019
Q4
$4.43M Buy
860,319
+231
+0% +$1.22K ﹤0.01% 2650
2019
Q3
$5.1M Sell
860,088
-2,831
-0.3% -$15.7K ﹤0.01% 2587
2019
Q2
$5.5M Sell
862,919
-13,320
-2% -$80.8K ﹤0.01% 2607
2019
Q1
$5.09M Sell
876,239
-4,009
-0.5% -$23.3K ﹤0.01% 2643
2018
Q4
$5.55M Buy
880,248
+1,900
+0.2% +$11.4K ﹤0.01% 2574
2018
Q3
$5.01M Buy
878,348
+5,674
+0.7% +$33.4K ﹤0.01% 2685
2018
Q2
$5.35M Sell
872,674
-10,411
-1% -$65.1K ﹤0.01% 2641
2018
Q1
$5.9M Sell
883,085
-5,326
-0.6% -$36.7K ﹤0.01% 2571
2017
Q4
$6.59M Buy
888,411
+16,324
+2% +$120K ﹤0.01% 2519
2017
Q3
$6.16M Buy
872,087
+5,804
+0.7% +$40.1K ﹤0.01% 2537
2017
Q2
$6.13M Buy
866,283
+2,464
+0.3% +$16.3K ﹤0.01% 2516
2017
Q1
$6M Buy
863,819
+10,843
+1% +$65.7K ﹤0.01% 2500
2016
Q4
$4.69M Buy
852,976
+2,791
+0.3% +$14.6K ﹤0.01% 2564
2016
Q3
$4.26M Sell
850,185
-322
-0% -$1.51K ﹤0.01% 2567
2016
Q2
$3.83M Sell
850,507
-2,004
-0.2% -$9.18K ﹤0.01% 2588
2016
Q1
$3.83M Sell
852,511
-1,325
-0.2% -$6.31K ﹤0.01% 2584
2015
Q4
$4.49M Buy
853,836
+1,872
+0.2% +$10.7K ﹤0.01% 2560
2015
Q3
$4.92M Sell
851,964
-1,683
-0.2% -$10.5K ﹤0.01% 2528
2015
Q2
$6.1M Buy
853,647
+6,512
+0.8% +$45.3K ﹤0.01% 2502
2015
Q1
$5.64M Sell
847,135
-2,551
-0.3% -$15.9K ﹤0.01% 2512
2014
Q4
$5.1M Buy
849,686
+847
+0.1% +$4.35K ﹤0.01% 2557
2014
Q3
$4.19M Sell
848,839
-7,742
-0.9% -$37.5K ﹤0.01% 2603
2014
Q2
$3.85M Buy
856,581
+123,202
+17% +$550K ﹤0.01% 2656
2014
Q1
$3.3M Buy
733,379
+4,373
+0.6% +$20.8K ﹤0.01% 2703
2013
Q4
$3.73M Sell
729,006
-7,403
-1% -$36.1K ﹤0.01% 2668
2013
Q3
$3.34M Sell
736,409
-1,285
-0.2% -$6.4K ﹤0.01% 2699
2013
Q2
$3.77M Buy
+737,694
New +$3.67M ﹤0.01% 2607

Other funds holding CPIX

Dimensional Fund Advisors's CPIX Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its Cumberland Pharmaceuticals (CPIX) stake by 16% in Q2 2026, selling an estimated $206K and leaving 233,305 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #2797.

Dimensional Fund Advisors first reported a position in CPIX in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.59M in Q4 2017. 20 funds tracked by Wall St. Rank hold CPIX as of Q2 2026.

  • Dimensional Fund Advisors held 233,305 shares of Cumberland Pharmaceuticals worth $1.51M as of Q2 2026.
  • Dimensional Fund Advisors sold 43,054 Cumberland Pharmaceuticals shares in Q2 2026, an estimated $206K.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2797 holding.
  • Dimensional Fund Advisors first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Dimensional Fund Advisors's Cumberland Pharmaceuticals position peaked at $6.59M in Q4 2017.
  • 20 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.